← Open Payments lookup

MICHAEL SIMS: Open Payments

NPI 1427053180 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,453 in 93 payments from 22 companies in 2025. Trend: 2023 $2,184 · 2024 $1,567 · 2025 $1,453

Food & beverage: $1,453
CompanyPaymentsAmount
Lilly USA, LLC15$194
ABBVIE INC.14$182
Novo Nordisk Inc11$178
GlaxoSmithKline, LLC.15$150
AstraZeneca Pharmaceuticals LP7$148
Corcept Therapeutics4$124
Axsome Therapeutics, Inc.4$93
PFIZER INC.5$78
Astellas Pharma US Inc2$44
Abbott Laboratories2$41

Products named: TRELEGY ELLIPTA, JARDIANCE, Korlym, AIRSUPRA, VRAYLAR, Rybelsus, Wegovy, Symbravo.

Industry payments across TX — which companies pay providers there.